COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK
26.79
25-April-25 15:45:00
15 minutes delayed
Stocks
+0.01
+0.04%
Today's range
26.22 - 27.09
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months Low: COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK
31 Dec 2024 11:35:28 By NetDania Notify
-
NetDania - New 12 months Low: COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK
30 Dec 2024 08:47:05 By NetDania Notify
-
NetDania - New 12 months Low: COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK
24 Dec 2024 08:48:22 By NetDania Notify
-
NetDania - New 12 months Low: COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK
23 Dec 2024 10:09:22 By NetDania Notify
-
Collegium to Participate in Upcoming Investor Conferences
12 Nov 2024 07:00:01 By Nasdaq GlobeNewswire
-
Collegium Reports Record Third Quarter 2024 Financial Results
07 Nov 2024 15:02:00 By Nasdaq GlobeNewswire
-
Collegium Appoints Vikram Karnani as Chief Executive Officer
07 Nov 2024 15:01:00 By Nasdaq GlobeNewswire
-
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
24 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months High: COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK
07 Oct 2024 08:45:26 By NetDania Notify
-
NetDania - New 12 months High: COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK
04 Oct 2024 09:14:59 By NetDania Notify
-
Collegium Completes Acquisition of Ironshore Therapeutics
04 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
30 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024
28 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Collegium Reports Second Quarter 2024 Financial Results
08 Aug 2024 15:01:00 By Nasdaq GlobeNewswire
-
Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
29 Jul 2024 05:00:00 By Nasdaq GlobeNewswire
-
Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024
25 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
13 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
Collegium to Participate in Jefferies Global Healthcare Conference
29 May 2024 07:00:01 By Nasdaq GlobeNewswire
-
Collegium Announces $35 Million Accelerated Share Repurchase Program
13 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Collegium Reports First Quarter 2024 Financial Results
09 May 2024 15:02:00 By Nasdaq GlobeNewswire